Abstracts

738 – Novel Quinazoline Derivatives Targeting SARS-CoV-2 RdRp With In Vitro and In Vivo Efficacy

Background Currently, direct-acting antivirals for SARS-CoV-2, such as remdesivir, molnupiravir, and nirmatrelvir, are widely used in clinical settings. These agents reduce viral load and mitigate disease severity and mortality. However, drug-resistant variants continue to emerge, highlighting the need for novel small-molecule antivirals that can be co-administered with existing therapies. Methods We synthesized more than 400…

752 – Long COVID Healthcare Stigma: Associations With Social Determinants of Health and Illness Severity

Background Long COVID has affected millions worldwide, with a disproportionate impact in high-risk communities due to social determinants of health (SDOH). Although stigma and provider dismissal are frequently described by Long COVID patients, few studies have systematically quantified healthcare-associated stigma or explored the intersection with SDOH and clinical severity. Understanding stigma is critical, as it…

757 – Neutrophil Dysfunction in Individuals With PASC With Pulmonary Sequelae

Background Although excessive neutrophil activation plays a pivotal role in hyperinflammatory complications in severe acute COVID-19, the role of neutrophils in the development of post-acute sequelae of SARS-CoV-2 (PASC) remains relatively unknown.  Methods We utilized cross-sectional blood samples from individuals with pulmonary PASC [PPASC, n=57] and two control groups (those infected with no residual symptoms…

497 – Development of a Novel Multiplex PCR for Rapid Diagnosis of Mpox, Syphilis, and Herpes Infections

Background Mpox is a significant emerging public health concern, with an increasing number of community transmission cases reported in the US. The virus spreads through close contact with infected individuals such as exposure during intercourse, often leading to the development of genital lesions. This pattern of transmission overlaps with a rise in sexually transmitted infections,…

784 – Population Pharmacokinetics of Rifampin & Pyrazinamide in Patients With TB: The Role of HbA1c & HIV

Background We have previously reported that tuberculosis (TB) patients with poorly controlled diabetes mellitus had a lower risk of adverse drug reactions (ADR), presumably due to low drug concentrations. Here, we focused on the two first-line sterilizing drugs, rifampicin (RIF) and pyrazinamide (PZA), in population pharmacokinetic (PopPK) models in TB patients receiving routine care. Methods…

267 – Host Environment Triggers 2 Distinct Trained Immunity Profiles in Elite Controllers

Background Elite Controllers (ECs) spontaneously maintain undetectable viral loads without antiretroviral therapy. Both viral and host genetic factors, including specific MHC alleles, contribute to control by promoting HIV-specific CD8⁺ T-cell responses. Virus-induced innate immunity can establish a sustained “trained” state that protects against heterologous infections. However, the contribution of innate and trained immunity to the…

1060 – Oral PrEP Persistence and Discontinuation in Spain: Insights From a National Multicenter Cohort

Background Oral pre-exposure prophylaxis (PrEP) with TDF/FTC is highly effective in preventing HIV infection, but its impact relies on sustained adherence and persistence. In Spain, PrEP is publicly funded and provided free of charge through the national health system. However, real-world data on PrEP retention and adherence remain limited, and structural challenges may hinder equitable…

876 – Comparing Molecular and Time-Space HIV Cluster Detection Methods in Rural Washington, 2020-2024

Background As part of the “Response” pillar of the Ending the HIV Epidemic Initiative, the CDC requires jurisdictions to use two methods to detect HIV transmission clusters: time-space (TS) and molecular HIV surveillance (MHS). TS methods use spatiotemporal proximity and MHS uses genetic distance. As the proportion of diagnoses in rural areas in Washington state…

899 – Beyond a Binary: Consistency of Transactional Sex Reporting and HIV-Related Risks Among Men

Background Although research on the epidemiology of transactional sex among men has grown, few studies examine this behavior longitudinally. The objective of this study was to examine the prevalence and correlates of transactional sex among men comparing those who reported transactional sex intermittently with those who reported engaging in transactional sex consistently over time. Methods…

1092 – Twenty-Three Million Years of Life: Survival Benefits of Antiretroviral Therapy for HIV in the US

Background Life expectancy of people with HIV on antiretroviral therapy (ART) has increased dramatically over the last 30 years. Our objective was to determine the aggregate clinical benefit of ART in the US. Methods Using a microsimulation model of HIV disease, we projected lifetime survival benefits for people initiating ART since 1996. We simulated ART regimens…